FINWIRES · TerminalLIVE
FINWIRES

Goldman Sachs Adjusts AbbVie Price Target to $244 From $240

By

AbbVie (ABBV) has an average rating of overweight and mean price target of $253.15, according to analysts polled by FactSet.

Price: $212.19, Change: $+8.30, Percent Change: +4.07%

Related Articles